APO Research

APO RESEARCH · REPORT

Test Phantoms

This report studies the Test Phantoms market, Test Phantoms can ensure your patients are receiving maximum image quality at the lowest possible dose.

Product & engineering

Understand the product.

This report studies the Test Phantoms market, Test Phantoms can ensure your patients are receiving maximum image quality at the lowest possible dose.

Selected research

Market Outlook & Growth Opportunities

Global Test Phantoms Market Outlook and Growth Opportunities 2026

Market perspective

This report studies the Test Phantoms market, Test Phantoms can ensure your patients are receiving maximum image quality at the lowest possible dose.

The major players in global Test Phantoms market include Gammex, Fluke, IBA, etc. The top 3 players occupy about 30% shares of the global market. North America and Europe are main markets, they occupy over 60% of the global market. CT Test Phantoms is the main type, with a share over 40%. Hospital and Research Institute are the key applications, which hold a share about 70%.

This report provides an overview of the global Test Phantoms market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Test Phantoms and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Test Phantoms sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Test Phantoms market size, projected growth trends, production technologies, key applications, and end-use industries.

Test Phantoms Segment by Company

Gammex

Fluke

IBA

Standard Imaging

Biodex Medical Systems

RaySafe

Capintec

Pro-Project

The Phantom Laboratory

Carville

CIRS

Modus Medical Devices

Radiology Support Devices

3-Dmed

Kyoto Kagaku

Test Phantoms Segment by Type

CT Test Phantoms

Mammography Test Phantoms

Ultrasound Test Phantoms

Radiation Oncology Test Phantoms

MRI Test Phantoms

Others

Test Phantoms Segment by Application

Research Institute

School

Hospital

Others

Test Phantoms Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Test Phantoms status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Test Phantoms market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Test Phantoms significant trends, drivers, influence factors in global and regions.

6. To analyze Test Phantoms competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Test Phantoms market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Test Phantoms and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Test Phantoms.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Test Phantoms market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Test Phantoms industry.

Chapter 3: Detailed analysis of Test Phantoms manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Test Phantoms in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Test Phantoms in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Test Phantoms Industry Trends Table 2. Test Phantoms Industry Drivers Table 3. Test Phantoms Industry Opportunities and Challenges Table 4. Test Phantoms Industry Restraints Table 5. Global Test Phantoms Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Test Phantoms Revenue Share by Company (2021-2026) Table 7. Global Test Phantoms Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Test Phantoms Sales Volume Share by Company (2021-2026) Table 9. Global Test Phantoms Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Test Phantoms Company Ranking, (2024-2026) & (USD Million) Table 11. Global Test Phantoms Key Company Manufacturing Base & Headquarters Table 12. Global Test Phantoms Company, Product Type & Application Table 13. Global Test Phantoms Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Test Phantoms by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of CT Test Phantoms Table 18. Significant Companies of Mammography Test Phantoms Table 19. Significant Companies of Ultrasound Test Phantoms Table 20. Significant Companies of Radiation Oncology Test Phantoms Table 21. Significant Companies of MRI Test Phantoms Table 22. Significant Companies of Others Table 23. Global Test Phantoms Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Test Phantoms Sales Volume by Type (2021-2026) & (K Units) Table 25. Global Test Phantoms Sales Volume by Type (2027-2032) & (K Units) Table 26. Global Test Phantoms Sales Volume Share by Type (2021-2026) Table 27. Global Test Phantoms Sales Volume Share by Type (2027-2032) Table 28. Global Test Phantoms Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Test Phantoms Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Test Phantoms Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Test Phantoms Sales Value Share by Type (2021-2026) Table 32. Global Test Phantoms Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Research Institute Table 34. Significant Companies of School Table 35. Significant Companies of Hospital Table 36. Significant Companies of Others Table 37. Global Test Phantoms Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Test Phantoms Sales Volume by Application (2021-2026) & (K Units) Table 39. Global Test Phantoms Sales Volume by Application (2027-2032) & (K Units) Table 40. Global Test Phantoms Sales Volume Share by Application (2021-2026) Table 41. Global Test Phantoms Sales Volume Share by Application (2027-2032) Table 42. Global Test Phantoms Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Test Phantoms Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Test Phantoms Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Test Phantoms Sales Value Share by Application (2021-2026) Table 46. Global Test Phantoms Sales Value Share by Application (2027-2032) Table 47. Global Test Phantoms Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 48. Global Test Phantoms Sales by Region (2021-2026) & (K Units) Table 49. Global Test Phantoms Sales Market Share by Region (2021-2026) Table 50. Global Test Phantoms Sales by Region (2027-2032) & (K Units) Table 51. Global Test Phantoms Sales Market Share by Region (2027-2032) Table 52. Global Test Phantoms Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Test Phantoms Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Test Phantoms Sales Value Share by Region (2021-2026) Table 55. Global Test Phantoms Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Test Phantoms Sales Value Share by Region (2027-2032) Table 57. Global Test Phantoms Market Average Price (US$/Unit) by Region (2021-2026) Table 58. Global Test Phantoms Market Average Price (US$/Unit) by Region (2027-2032) Table 59. Global Test Phantoms Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Global Test Phantoms Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Test Phantoms Sales by Country (2021-2026) & (K Units) Table 62. Global Test Phantoms Sales Market Share by Country (2021-2026) Table 63. Global Test Phantoms Sales by Country (2027-2032) & (K Units) Table 64. Global Test Phantoms Sales Market Share by Country (2027-2032) Table 65. Global Test Phantoms Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Test Phantoms Sales Value Market Share by Country (2021-2026) Table 67. Global Test Phantoms Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Test Phantoms Sales Value Market Share by Country (2027-2032) Table 69. Gammex Company Information Table 70. Gammex Business Overview Table 71. Gammex Test Phantoms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Gammex Test Phantoms Product Portfolio Table 73. Gammex Recent Development Table 74. Fluke Company Information Table 75. Fluke Business Overview Table 76. Fluke Test Phantoms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Fluke Test Phantoms Product Portfolio Table 78. Fluke Recent Development Table 79. IBA Company Information Table 80. IBA Business Overview Table 81. IBA Test Phantoms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. IBA Test Phantoms Product Portfolio Table 83. IBA Recent Development Table 84. Standard Imaging Company Information Table 85. Standard Imaging Business Overview Table 86. Standard Imaging Test Phantoms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Standard Imaging Test Phantoms Product Portfolio Table 88. Standard Imaging Recent Development Table 89. Biodex Medical Systems Company Information Table 90. Biodex Medical Systems Business Overview Table 91. Biodex Medical Systems Test Phantoms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Biodex Medical Systems Test Phantoms Product Portfolio Table 93. Biodex Medical Systems Recent Development Table 94. RaySafe Company Information Table 95. RaySafe Business Overview Table 96. RaySafe Test Phantoms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. RaySafe Test Phantoms Product Portfolio Table 98. RaySafe Recent Development Table 99. Capintec Company Information Table 100. Capintec Business Overview Table 101. Capintec Test Phantoms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Capintec Test Phantoms Product Portfolio Table 103. Capintec Recent Development Table 104. Pro-Project Company Information Table 105. Pro-Project Business Overview Table 106. Pro-Project Test Phantoms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Pro-Project Test Phantoms Product Portfolio Table 108. Pro-Project Recent Development Table 109. The Phantom Laboratory Company Information Table 110. The Phantom Laboratory Business Overview Table 111. The Phantom Laboratory Test Phantoms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. The Phantom Laboratory Test Phantoms Product Portfolio Table 113. The Phantom Laboratory Recent Development Table 114. Carville Company Information Table 115. Carville Business Overview Table 116. Carville Test Phantoms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Carville Test Phantoms Product Portfolio Table 118. Carville Recent Development Table 119. CIRS Company Information Table 120. CIRS Business Overview Table 121. CIRS Test Phantoms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. CIRS Test Phantoms Product Portfolio Table 123. CIRS Recent Development Table 124. Modus Medical Devices Company Information Table 125. Modus Medical Devices Business Overview Table 126. Modus Medical Devices Test Phantoms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Modus Medical Devices Test Phantoms Product Portfolio Table 128. Modus Medical Devices Recent Development Table 129. Radiology Support Devices Company Information Table 130. Radiology Support Devices Business Overview Table 131. Radiology Support Devices Test Phantoms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Radiology Support Devices Test Phantoms Product Portfolio Table 133. Radiology Support Devices Recent Development Table 134. 3-Dmed Company Information Table 135. 3-Dmed Business Overview Table 136. 3-Dmed Test Phantoms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. 3-Dmed Test Phantoms Product Portfolio Table 138. 3-Dmed Recent Development Table 139. Kyoto Kagaku Company Information Table 140. Kyoto Kagaku Business Overview Table 141. Kyoto Kagaku Test Phantoms Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Kyoto Kagaku Test Phantoms Product Portfolio Table 143. Kyoto Kagaku Recent Development Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Test Phantoms Distributors List Table 147. Test Phantoms Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Test Phantoms Product Image Figure 2. Global Test Phantoms Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Test Phantoms Sales Value (2021-2032) & (US$ Million) Figure 4. Global Test Phantoms Sales (2021-2032) & (K Units) Figure 5. Global Test Phantoms Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Test Phantoms Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. CT Test Phantoms Image Figure 10. Mammography Test Phantoms Image Figure 11. Ultrasound Test Phantoms Image Figure 12. Radiation Oncology Test Phantoms Image Figure 13. MRI Test Phantoms Image Figure 14. Others Image Figure 15. Global Test Phantoms Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Test Phantoms Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Test Phantoms Sales Volume Share by Type (2021-2032) Figure 18. Global Test Phantoms Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Test Phantoms Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Test Phantoms Sales Value Share by Type (2021-2032) Figure 21. Research Institute Image Figure 22. School Image Figure 23. Hospital Image Figure 24. Others Image Figure 25. Global Test Phantoms Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Test Phantoms Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Test Phantoms Sales Volume Share by Application (2021-2032) Figure 28. Global Test Phantoms Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Test Phantoms Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Test Phantoms Sales Value Share by Application (2021-2032) Figure 31. Global Test Phantoms Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 32. Global Test Phantoms Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Test Phantoms Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Test Phantoms Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Test Phantoms Sales Value (2021-2032) & (US$ Million) Figure 36. North America Test Phantoms Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Test Phantoms Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Test Phantoms Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Test Phantoms Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Test Phantoms Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Test Phantoms Sales Value (2021-2032) & (US$ Million) Figure 42. South America Test Phantoms Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Test Phantoms Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Test Phantoms Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Test Phantoms Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Test Phantoms Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Test Phantoms Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Test Phantoms Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Test Phantoms Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • CT Test Phantoms
  • Mammography Test Phantoms
  • Ultrasound Test Phantoms
  • Radiation Oncology Test Phantoms
  • MRI Test Phantoms
  • Others
Applications
  • Research Institute
  • School
  • Hospital
  • Others
Companies covered
  • Gammex
  • Fluke
  • IBA
  • Standard Imaging
  • Biodex Medical Systems
  • RaySafe
  • Capintec
  • Pro-Project
  • The Phantom Laboratory
  • Carville
  • CIRS
  • Modus Medical Devices
  • Radiology Support Devices
  • 3-Dmed
  • Kyoto Kagaku

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Test Phantoms Sales Value (2021-2032)
  4. 1.2.2 Global Test Phantoms Sales Volume (2021-2032)
  5. 1.2.3 Global Test Phantoms Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Test Phantoms Market Dynamics
  1. 2.1 Test Phantoms Industry Trends
  2. 2.2 Test Phantoms Industry Drivers
  3. 2.3 Test Phantoms Industry Opportunities and Challenges
  4. 2.4 Test Phantoms Industry Restraints
3 Test Phantoms Market by Company
  1. 3.1 Global Test Phantoms Company Revenue Ranking in 2025
  2. 3.2 Global Test Phantoms Revenue by Company (2021-2026)
  3. 3.3 Global Test Phantoms Sales Volume by Company (2021-2026)
  4. 3.4 Global Test Phantoms Average Price by Company (2021-2026)
  5. 3.5 Global Test Phantoms Company Ranking (2024-2026)
  6. 3.6 Global Test Phantoms Company Manufacturing Base and Headquarters
  7. 3.7 Global Test Phantoms Company Product Type and Application
  8. 3.8 Global Test Phantoms Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Test Phantoms Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Test Phantoms Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Test Phantoms Market by Type
  1. 4.1 Test Phantoms Type Introduction
  2. 4.1.1 CT Test Phantoms
  3. 4.1.2 Mammography Test Phantoms
  4. 4.1.3 Ultrasound Test Phantoms
  5. 4.1.4 Radiation Oncology Test Phantoms
  6. 4.1.5 MRI Test Phantoms
  7. 4.1.6 Others
  8. 4.2 Global Test Phantoms Sales Volume by Type
  9. 4.2.1 Global Test Phantoms Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Test Phantoms Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Test Phantoms Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Test Phantoms Sales Value by Type
  13. 4.3.1 Global Test Phantoms Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Test Phantoms Sales Value by Type (2021-2032)
  15. 4.3.3 Global Test Phantoms Sales Value Share by Type (2021-2032)
5 Test Phantoms Market by Application
  1. 5.1 Test Phantoms Application Introduction
  2. 5.1.1 Research Institute
  3. 5.1.2 School
  4. 5.1.3 Hospital
  5. 5.1.4 Others
  6. 5.2 Global Test Phantoms Sales Volume by Application
  7. 5.2.1 Global Test Phantoms Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Test Phantoms Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Test Phantoms Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Test Phantoms Sales Value by Application
  11. 5.3.1 Global Test Phantoms Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Test Phantoms Sales Value by Application (2021-2032)
  13. 5.3.3 Global Test Phantoms Sales Value Share by Application (2021-2032)
6 Test Phantoms Regional Sales and Value Analysis
  1. 6.1 Global Test Phantoms Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Test Phantoms Sales by Region (2021-2032)
  3. 6.2.1 Global Test Phantoms Sales by Region: 2021-2026
  4. 6.2.2 Global Test Phantoms Sales by Region (2027-2032)
  5. 6.3 Global Test Phantoms Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Test Phantoms Sales Value by Region (2021-2032)
  7. 6.4.1 Global Test Phantoms Sales Value by Region: 2021-2026
  8. 6.4.2 Global Test Phantoms Sales Value by Region (2027-2032)
  9. 6.5 Global Test Phantoms Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Test Phantoms Sales Value (2021-2032)
  12. 6.6.2 North America Test Phantoms Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Test Phantoms Sales Value (2021-2032)
  15. 6.7.2 Europe Test Phantoms Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Test Phantoms Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Test Phantoms Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Test Phantoms Sales Value (2021-2032)
  21. 6.9.2 South America Test Phantoms Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Test Phantoms Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Test Phantoms Sales Value Share by Country, 2025 VS 2032
7 Test Phantoms Country-level Sales and Value Analysis
  1. 7.1 Global Test Phantoms Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Test Phantoms Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Test Phantoms Sales by Country (2021-2032)
  4. 7.3.1 Global Test Phantoms Sales by Country (2021-2026)
  5. 7.3.2 Global Test Phantoms Sales by Country (2027-2032)
  6. 7.4 Global Test Phantoms Sales Value by Country (2021-2032)
  7. 7.4.1 Global Test Phantoms Sales Value by Country (2021-2026)
  8. 7.4.2 Global Test Phantoms Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Test Phantoms Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Test Phantoms Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Test Phantoms Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Test Phantoms Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Test Phantoms Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Test Phantoms Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Test Phantoms Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Test Phantoms Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Test Phantoms Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Test Phantoms Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Test Phantoms Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Test Phantoms Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Test Phantoms Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Test Phantoms Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Test Phantoms Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Test Phantoms Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Test Phantoms Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Test Phantoms Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Test Phantoms Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Test Phantoms Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Test Phantoms Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Test Phantoms Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Test Phantoms Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Test Phantoms Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Test Phantoms Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Test Phantoms Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Test Phantoms Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Test Phantoms Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Test Phantoms Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Test Phantoms Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Test Phantoms Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Test Phantoms Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Test Phantoms Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Test Phantoms Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Test Phantoms Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Test Phantoms Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Test Phantoms Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Test Phantoms Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Test Phantoms Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Test Phantoms Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Test Phantoms Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Test Phantoms Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Test Phantoms Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Test Phantoms Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Test Phantoms Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Test Phantoms Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Test Phantoms Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Test Phantoms Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Test Phantoms Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Test Phantoms Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Test Phantoms Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Test Phantoms Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Test Phantoms Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Test Phantoms Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Test Phantoms Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Test Phantoms Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Test Phantoms Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Test Phantoms Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Test Phantoms Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Test Phantoms Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Test Phantoms Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Test Phantoms Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Test Phantoms Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Test Phantoms Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Test Phantoms Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Test Phantoms Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Test Phantoms Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Test Phantoms Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Test Phantoms Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Test Phantoms Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Test Phantoms Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Test Phantoms Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Test Phantoms Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Test Phantoms Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Test Phantoms Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Test Phantoms Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Test Phantoms Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Test Phantoms Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Test Phantoms Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Test Phantoms Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Test Phantoms Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Test Phantoms Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Test Phantoms Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Test Phantoms Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Gammex
  2. 8.1.1 Gammex Company Information
  3. 8.1.2 Gammex Business Overview
  4. 8.1.3 Gammex Test Phantoms Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Gammex Test Phantoms Product Portfolio
  6. 8.1.5 Gammex Recent Developments
  7. 8.2 Fluke
  8. 8.2.1 Fluke Company Information
  9. 8.2.2 Fluke Business Overview
  10. 8.2.3 Fluke Test Phantoms Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Fluke Test Phantoms Product Portfolio
  12. 8.2.5 Fluke Recent Developments
  13. 8.3 IBA
  14. 8.3.1 IBA Company Information
  15. 8.3.2 IBA Business Overview
  16. 8.3.3 IBA Test Phantoms Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 IBA Test Phantoms Product Portfolio
  18. 8.3.5 IBA Recent Developments
  19. 8.4 Standard Imaging
  20. 8.4.1 Standard Imaging Company Information
  21. 8.4.2 Standard Imaging Business Overview
  22. 8.4.3 Standard Imaging Test Phantoms Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Standard Imaging Test Phantoms Product Portfolio
  24. 8.4.5 Standard Imaging Recent Developments
  25. 8.5 Biodex Medical Systems
  26. 8.5.1 Biodex Medical Systems Company Information
  27. 8.5.2 Biodex Medical Systems Business Overview
  28. 8.5.3 Biodex Medical Systems Test Phantoms Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Biodex Medical Systems Test Phantoms Product Portfolio
  30. 8.5.5 Biodex Medical Systems Recent Developments
  31. 8.6 RaySafe
  32. 8.6.1 RaySafe Company Information
  33. 8.6.2 RaySafe Business Overview
  34. 8.6.3 RaySafe Test Phantoms Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 RaySafe Test Phantoms Product Portfolio
  36. 8.6.5 RaySafe Recent Developments
  37. 8.7 Capintec
  38. 8.7.1 Capintec Company Information
  39. 8.7.2 Capintec Business Overview
  40. 8.7.3 Capintec Test Phantoms Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Capintec Test Phantoms Product Portfolio
  42. 8.7.5 Capintec Recent Developments
  43. 8.8 Pro-Project
  44. 8.8.1 Pro-Project Company Information
  45. 8.8.2 Pro-Project Business Overview
  46. 8.8.3 Pro-Project Test Phantoms Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Pro-Project Test Phantoms Product Portfolio
  48. 8.8.5 Pro-Project Recent Developments
  49. 8.9 The Phantom Laboratory
  50. 8.9.1 The Phantom Laboratory Company Information
  51. 8.9.2 The Phantom Laboratory Business Overview
  52. 8.9.3 The Phantom Laboratory Test Phantoms Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 The Phantom Laboratory Test Phantoms Product Portfolio
  54. 8.9.5 The Phantom Laboratory Recent Developments
  55. 8.10 Carville
  56. 8.10.1 Carville Company Information
  57. 8.10.2 Carville Business Overview
  58. 8.10.3 Carville Test Phantoms Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Carville Test Phantoms Product Portfolio
  60. 8.10.5 Carville Recent Developments
  61. 8.11 CIRS
  62. 8.11.1 CIRS Company Information
  63. 8.11.2 CIRS Business Overview
  64. 8.11.3 CIRS Test Phantoms Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 CIRS Test Phantoms Product Portfolio
  66. 8.11.5 CIRS Recent Developments
  67. 8.12 Modus Medical Devices
  68. 8.12.1 Modus Medical Devices Company Information
  69. 8.12.2 Modus Medical Devices Business Overview
  70. 8.12.3 Modus Medical Devices Test Phantoms Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Modus Medical Devices Test Phantoms Product Portfolio
  72. 8.12.5 Modus Medical Devices Recent Developments
  73. 8.13 Radiology Support Devices
  74. 8.13.1 Radiology Support Devices Company Information
  75. 8.13.2 Radiology Support Devices Business Overview
  76. 8.13.3 Radiology Support Devices Test Phantoms Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Radiology Support Devices Test Phantoms Product Portfolio
  78. 8.13.5 Radiology Support Devices Recent Developments
  79. 8.14 3-Dmed
  80. 8.14.1 3-Dmed Company Information
  81. 8.14.2 3-Dmed Business Overview
  82. 8.14.3 3-Dmed Test Phantoms Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 3-Dmed Test Phantoms Product Portfolio
  84. 8.14.5 3-Dmed Recent Developments
  85. 8.15 Kyoto Kagaku
  86. 8.15.1 Kyoto Kagaku Company Information
  87. 8.15.2 Kyoto Kagaku Business Overview
  88. 8.15.3 Kyoto Kagaku Test Phantoms Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Kyoto Kagaku Test Phantoms Product Portfolio
  90. 8.15.5 Kyoto Kagaku Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Test Phantoms Value Chain Analysis
  2. 9.1.1 Test Phantoms Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Test Phantoms Sales Mode & Process
  6. 9.2 Test Phantoms Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Test Phantoms Distributors
  9. 9.2.3 Test Phantoms Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research